Background. Approximately 10-30% of IDDM patients develop diabetic nephropathy depending on the metabolic control. Previous examinations on the significance of the kidney size prior to the manifestation of nephropathy produced varying results. Methods. The present study, therefore, was designed to assess the correlation between sonographically determined kidney size and kidney function over 8 years in a follow-up examination, and to evaluate a potential risk pattern. Data could be collected from 73 (66%) of 110 IDDM patients with initially normal serum creatinine whose sonographically determined kidney volume (cm 3 = L cm x W cm x D cm x 7i/6) and kidney function (creatinine, albuminuria, /^-microglobulin in serum) had been examined in 1986, and who had a diabetes duration of 1 month to 25 years at that time. Results. 30% (11 of 37) patients with large kidneys (>170cm 3 ) reached at least one serious renal endpoint (increase of serum creatinine by more than 50%, requirement of dialysis or kidney transplantation, or death in end-stage renal disease) versus one of 36 patients with normal kidney size (P<0.002). As many as 42% of patients with large kidneys developed abnormal creatinine values (>106umol/l) in contrast to only 20% of the patients with normal kidney volume (P<0.05). Six of seven patients with a more than 50% increase of serum creatinine from baseline showed large kidneys in 1986, but had a normal serum creatinine, and four also a normal urine albumin excretion. Furthermore all five patients with more severe endpoints (two deaths in end-stage renal disease and three patients presently requiring dialysis) exhibited either an increased serum creatinine or large kidneys at baseline; four of these, however, were still in the normoalbuminuric state in 1986. Conclusions. These results indicate that large kidneys might be a morphological marker for subsequent diabetic nephropathy, and as a consequence, renal insufficiency.
Introduction
Diabetic nephropathy is one of the most frequent causes of death in IDDM patients [1, 2] . Approximately 10-30% of IDDM patients develop diabetic nephropathy, depending on their long-term metabolic control, and the incidence of renal failure is still growing [3] [4] [5] . Hyperfunctional nephromegaly is frequently found in newly diagnosed diabetics [6, 7] . On the other hand, in the stage of terminal renal insufficiency diabetic kidneys are small [8] . The course of the decline in volume has so far hardly been examined systematically. Earlier cross-sectional studies carried out in 1986 by our group aimed at examining the correlation between the sonographically determined kidney size (kidney volume = KV) and the renal function of IDDM patients in exact relation to the duration of diabetes [9] . Diabetic patients with recent manifestation of IDDM did not show a significant change in the kidney size or renal function at that time. Nephromegaly did arise, however, after a diabetes duration of 6 months to 5 years. IDDM patients with moderate renal insufficiency also had sonographically large kidneys.
The present study was designed to perform a followup examination, 8 years later, of the IDDM patients investigated in 1986, and an attempt was made to establish a prognostic correlation between kidney size and the later manifestation of diabetic renal disease as a predefined endpoint.
Subjects and methods
In 1994, 73 of 110 IDDM patients with initially normal serum creatinine, who had been examined in 1986 and described in detail previously [9] , agreed to participate in a follow-up study (male « = 38, female » = 35). Table 1 gives the main clinical characteristics. Compared to the rest of the group in 1986, there were no significant differences in the baseline parameters between the patients with and without follow-up ( Table 2 ). As to the latter, the remaining 37 patients declined to be examined or were lost to follow-up, but were not different with respect to major determinants of renal prognosis. The study was performed in accordance with the Declaration of Helsinki. Approval was given by the local Ethical Committee and informed consent obtained from all patients investigated. A haemodynometry (mean values of systolic/diastolic blood pressure measured by two investigators on both arms at heart level in a sitting position) was carried out on the IDDM patients as well as a detailed history was taken, e.g. of diabetic complications, the use of medications, and changes in the living conditions during the past 8-year period.
KV was measured sonographically three times on both sides with the patient lying supine or in a semilateral position (Picker LS 7000, 3,5-Mhz semi-sector scan), the kidney volume was calculated according to the ellipsoidal formula volume (ml or cm 3 ) = length (cm) x width (cm) x depth (cm) x Tt/6 and the respective mean values of both kidneys were determined [6] . The results were then related to a body surface of 1.73 m 2 in order to account for the individual body size and weight. KV of more than 170 cm 3 was defined as large kidneys on the basis of results obtained in 44 agematched healthy control subjects without history of renal disease who exhibited a 90th KV percentile of 170 cm 3 , and a lower volume than 130 cm 3 was defined as small kidneys [9] . No difference in kidney size was found between male and female controls.
Laboratory methods were applied to determine the renal function parameters (serum creatinine, serum /J 2 -microglobulin, urine albumin concentration) as well as HbA lc . The serum creatinine (normal range 62-106 |imol/l ) was measured by means of a test kit produced by Roche/GrenzachWyhlen [10] . Creatinine clearence was calculated by the formula; (140-age) x weight/creatinine (in mg/100ml)x72 (normal range 95-160 ml/min). /^-Microglobulin was determined using a radioimmunoassay (Pharmacia/Uppsala, [11] ). The Behring kit was used to estimate the median albumin concentration in 24-h-urine on three occasions [12] . The values measured were expressed in mg/mmol creatinine (normal range < 3.4 mg/mmol creatinine). The HbA lc values were obtained by high-performance liquid chromatography.
Outcome end-points evaluated in the present study were (pre)defined as (1) an increase of serum creatinine by more than 50% of baseline, (2) requirement of dialysis, (3) kidney transplantation, or (4) death in end-stage renal disease. For outcome analysis only the most serious end-point was counted in each patient.
Statistical analysis
Results are given as mean + SD (SEM) or median values. Comparisons were made using the Wilcoxon rank test, Student's t test, or % 2 test as appropriate.
Results
As already referred to, Table 1 outlines the relevant clinical details of the 73 IDDM patients in 1986 and 1994. Mean kidney size remained about the same, with a large variation in the individual case, so did HbA lc , whereas the median values of kidney size decreased slightly, yet significantly. In contrast, serum creatinine and /^-microglobulin concentration had risen significantly during the 8-year observation period in addition to a significant increase of the mean urine albumin excretion. Concentrations of creatinine and ^-microglobulin were closely correlated (r=0.6038, P<0.001, data not shown).
To evaluate the outcome according to kidney size patients were stratified as well as for normal « 1 7 0 cm 3 ) and large (> 170 cm 3 ) kidney size at baseline (Table 3) . There were 36 patients with normal and 37 with large kidney size in 1986. These two groups turned out to be well matched and exhibited no significant differences in terms of albuminuria (which was on average in the normal range in both groups), creatinine clearence, serum creatinine, blood pressure, HbA lc , diabetes duration, age, and sex distribution (Table 3) . Overall, 42% of the IDDM patients who had large kidneys 8 years ago, developed abnormal creatinine values (>106 umol/1) versus only 20% in the group of patients with a kidney volume of under 170 cm 3 (P<0.05). As indicated in Table 4 , 30% (11 of 37) patients with large kidney size developed at least one of the serious renal outcome end-points denned, in contrast to one (3%) of those 36 patients with normal kidney size (P< 0.002, Table 4 ). Table 5 lists details of the seven individuals with a more than 50% increase of serum creatinine from 1986 to 1994. Six had large kidneys at baseline, but a normal serum creatinine, and four patients even showed a normal urin albumin excretion at that time (Table 5) . Only one patient with normal renal size at baseline exhibited an increase of more than 50% in serum creatinine. Table 6 summarizes the individual baseline data of the patients with the most severe end-points. Two patients died during the observation period in the stage of terminal renal insufficiency, and three had to undergo dialysis. The two deceased patients had a normal serum creatinine as well as a normal serum p 2 -microglobulin at baseline, but large kidneys, and a normal urine albumin excretion. In addition, three patients who now require dialysis displayed nephromegaly, yet normal serum creatinine values (two also normoalbuminuria) in 1986. Overall, a total of four patients with severe end-points listed in Table 6 showed neither increased albuminuria nor an increased serum creatinine, but large kidneys at baseline examination.
During the observation period up to 1994, new albuminuria (> 3.4 mg/mmol creat) occurred with values betweeen 8 and 71 mg/mmol creat in 11 of 52 patients who initially had normal serum creatinine. Considering kidney size, eight of 25 patients (32%) with large kidneys developed albuminuria, in contrast to three of 27 (11%) with normal KV, but no correlation was observed between kidney size and albuminuria in these patients. Since not all available patients could be examined for albuminuria at follow-up, no statistical end-point analysis was performed for this variable. Interestingly, however, restoration of normoalbuminuria was seen in three patients with normal KV compared to none of the patients with elevated KV and normal serum creatinine.
Discussion
This study demonstrates the high risk of IDDM patients with sonographically determined large kidneys to progress to more severe diabetic renal disease. During a follow-up period of 8 years, 30% of patients with large kidneys but normal serum creatinine at baseline developed at least one serious renal end-point compared to only one patient with a normal kidney volume in 1986. Apart from kidney size, these two groups of patients showed no other differences in terms of clinical characteristics at baseline. Six of seven patients with an increase of serum creatinine of more than 50% had large kidneys at baseline, but only two showed also elevated albuminuria at that time. Of the two deceased patients both had large kidneys in 1986. Conversely, none of the patients with normal KV and normal serum creatinine at baseline died during the 8-year follow-up period. An analogous observation was made in patients requiring dialysis: all three had initially large kidneys. None with normal KV and normal creatinine progressed to a dialysis-requiring stage. Concerning urine albumin excretion both deceased and two of the three dialysiswith large and normal kidney size (mean + SD) . F, female; M, male; DD, diabetes duration; BP, systolic/diastolic blood pressure; Cr, serum creatinine; Cr cl , creatinine clearance; UAE, urine albumin excretion. "Median value b mg/mmol creatinine; n.s., not significant. Prognosis of IDDM patients with large kidneys requiring patients still exhibited normoalbuminuria, yet large kidneys at baseline. These results should by no means be interpreted as disproving the predictive importance of increased urine albumin excretion in IDDM patients [13] since the study was designed rather to evaluate the impact of large kidneys, but they underline that-in addition to the state of albuminuria-kidney size seems to be another determinant of the renal outcome. Interestingly, microalbuminuria reverted to normal only in patients with a normal KV over the 8-year period. On the other hand, it has long been known that IDDM patients with microalbuminuria have a higher KV compared to patients with normal urinary albumin excretion [14, 15] . Controversy exists, however, as to whether kidney size, estimated by ultrasound or X-ray, may still be modulated after years of IDDM and during the microalbuminuric state [16, 17] . An 'autonomous' persistent nephromegaly has been observed in earlier studies of IDDM patients, in contrast to a reversibility of glomerular hyperperfusion and an enhanced GFR [18, 19] . Glomerular hyperperfusion has not been found to predict diabetic nephropathy in IDDM patients [6] .
In the present study KV of more than 170 cm 3 was defined as large kidneys on the basis of results obtained in age-matched healthy control subjects, and values were adjusted to 1.73 m 2 body-surface area. This cutoff level for large kidneys is somewhat lower compared to a previous study [15] . The reasons for that remain unclear, although one possible explanation is the use of a new generation of semi-sector scan and ultrasound equipment, where both kidneys can be examined instead of only the right kidney as earlier described [15] .
Patients included in the present study showed a wide spectrum of duration of IDDM from newly diagnosed up to over 45 years. Only a minority had a diabetes duration of less than 0.5 years (16%), and mean duration in 1986 was 9.8 + 3.1 years. Since the incidence of diabetic nephropathy (usually defined as macroproteinuria) seems to peak after some 15 years of IDDM [20] , a high likelihood for the occurrence of the defined kidney end-points probably existed in the study cohort during the 8 year follow-up. This fact might have contributed to the findings of this study which contrast to earlier results stating that single measurements of kidney volume add little to the prognosis of the renal outcome of IDDM patients [17, 21] .
A weakness of the present study consists in the incomplete follow-up of patients, but fortunately over two-thirds of the original cohort of patients could be included, and the baseline characteristics of these patients did not differ significantly from those not investigated. Given this limitation the investigation of KV by ultrasound nevertheless seems to be of predictive importance for the renal outcome of IDDM patients, and sonographically large kidneys appear to carry a considerable risk. The non-invasive ultrasound technique is available with high reproducibility based on today's excellent imaging quality, and could therefore be used as an additional measure to AER in the screening of high-risk IDDM individuals for diabetic nephropathy.
